Package 51662-1657-1

{"route": ["INTRAVENOUS"], "spl_id": "1bf999b5-e291-dcbd-e063-6294a90a2bab", "openfda": {"unii": ["V13007Z41A"], "rxcui": ["1737723"], "spl_set_id": ["1bf999b5-e290-dcbd-e063-6294a90a2bab"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 BAG (51662-1657-1)", "package_ndc": "51662-1657-1", "marketing_start_date": "19810422"}], "brand_name": "LIDOCAINE HYDROCHLORIDE AND DEXTROSE", "product_id": "51662-1657_1bf999b5-e291-dcbd-e063-6294a90a2bab", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Local Anesthesia [PE]"], "product_ndc": "51662-1657", "generic_name": "LIDOCAINE HYDROCHLORIDE AND DEXTROSE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LIDOCAINE HYDROCHLORIDE AND DEXTROSE", "active_ingredients": [{"name": "LIDOCAINE HYDROCHLORIDE", "strength": "8 mg/mL"}], "application_number": "NDA018461", "marketing_category": "NDA", "marketing_start_date": "19810422", "listing_expiration_date": "20261231"}